This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Hookipa Biotech Gmbh. Active years: 2018-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2023
Title: **Gerhard Fuhrmann: A Pioneer in Vaccine Development**
Introduction
Gerhard Fuhrmann, an esteemed inventor based in Vienna, Austria, has made remarkable contributions to the field of biotechnology. With four patents to his name, Fuhrmann’s innovative work focuses primarily on vaccine development aimed at addressing significant health challenges, including cytomegalovirus (CMV) and human papillomavirus (HPV) infections.
Latest Patents
Fuhrmann’s latest patents showcase his commitment to advancing medical science. His work on CMV vaccines includes genetically modified arenaviral vectors that are engineered as vaccines for both the prevention and treatment of CMV infections and reactivation. These patents encompass pharmaceutical compositions and methods designed to combat cytomegalovirus effectively.
In addition, Fuhrmann's ingenuity extends to the development of HPV vaccines, which utilize genetically modified arenaviruses to target neoplastic diseases, including various forms of cancer linked to oncogenic viruses. His inventions also include pharmaceutical compositions and innovative methods aimed at preventing and treating conditions caused by HPV, such as cervical cancer and other related cancers.
Career Highlights
Fuhrmann’s professional journey has been marked by his dedication to research and innovation in the field of biotechnology. He currently works at Hookipa Biotech GmbH, a company that focuses on developing innovative therapies based on their proprietary platform. His expertise and dedication have allowed him to achieve noteworthy success in creating vaccines that have the potential to save lives.
Collaborations
Throughout his career, Fuhrmann has collaborated with renowned experts in the field. Notable colleagues include Klaus Orlinger and Thomas P Monath, with whom he shares a commitment to advancing biotechnology and vaccine development. These collaborations have facilitated the exchange of ideas and fostered innovative solutions to complex health challenges.
Conclusion
Gerhard Fuhrmann stands out as a significant figure in the realm of vaccine research and development. Through his inventive work and valuable collaborations, he continues to contribute to the protection of public health against viral infections and related diseases. His commitment to scientific excellence propels him forward as he seeks to make a meaningful impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile